Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN) Multicenter Randomized Phase II Clinical Trial

NCT05617716 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT05617716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05617716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Spine Patient Optimal Radiosurgery Treatment for Symptomatic Metastatic Neoplasms (SPORTSMEN) Multicenter Randomized Phase II Clinical Trial
Lead sponsor
University of Oklahoma
Phase
Phase 2
Overall status
Recruiting
Start date
September 9, 2025
Completion date
September 30, 2029
Enrollment
240 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic neoplasm, metastatic neoplasm to the spine